Published in Am J Gastroenterol on November 01, 2004
Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30
Bacterial communities from shoreline environments (costa da morte, northwestern Spain) affected by the prestige oil spill. Appl Environ Microbiol (2009) 1.16
Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status. PLoS One (2013) 1.15
Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol (2011) 0.90
Targeting the diverse immunological functions expressed by hepatic NKT cells. Expert Opin Ther Targets (2011) 0.86
No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England. Am J Epidemiol (2014) 0.84
Novosphingobium and its potential role in chronic obstructive pulmonary diseases: insights from microbiome studies. PLoS One (2014) 0.82
Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis. Arch Med Sci (2011) 0.80
Autoantibodies to muscarinic acetylcholine receptors found in patients with primary biliary cirrhosis. BMC Gastroenterol (2010) 0.79
Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther (2015) 0.78
Genetic susceptibility to autoimmune liver disease. World J Hepatol (2011) 0.77
Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis. J Clin Immunol (2012) 0.76
Concept on the pathogenesis and treatment of primary biliary cirrhosis. World J Gastroenterol (2006) 0.75
Autoimmune disease triggered by infection with alphaproteobacteria. Expert Rev Clin Immunol (2009) 0.75
Comparative Genomic Analysis Reveals Habitat-Specific Genes and Regulatory Hubs within the Genus Novosphingobium. mSystems (2017) 0.75
Alanine aminotransferase levels: what's normal? Ann Intern Med (2002) 2.17
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Aerobic capacity is associated with 100-day outcome after hepatic transplantation. Liver Transpl (2004) 1.00
The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology (2013) 0.95
The natural history of PBC: has it changed? Semin Liver Dis (2005) 0.91
Management of primary sclerosing cholangitis. Am J Gastroenterol (2002) 0.88
Statins in primary biliary cirrhosis: are they safe? Dig Dis Sci (2009) 0.86
A pilot study of etanercept in the treatment of primary sclerosing cholangitis. Dig Dis Sci (2004) 0.84
Primary biliary cirrhosis: past, present, and future. Gastroenterology (2002) 0.82
Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis. Hepatology (2002) 0.81
Steroid-responsive (autoimmune?) sclerosing cholangitis. Dig Dis Sci (2005) 0.81
Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. Am J Gastroenterol (2003) 0.81
Persistent cholestatic jaundice after ERCP. Am J Gastroenterol (2006) 0.81
Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol (2011) 0.80
Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology (2007) 0.80
Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol (2011) 0.79
Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience. Dig Dis Sci (2008) 0.79
Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia. Am J Gastroenterol (2004) 0.76
Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci (2010) 0.76
Modafinil for the treatment of fatigue in primary biliary cirrhosis. Ann Intern Med (2005) 0.76
Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Dig Dis Sci (2005) 0.76
Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol. Hepatology (2009) 0.75
Reversible hepatic decompensation in primary biliary cirrhosis due to hypercoagulability. Ann Intern Med (2007) 0.75
Pericentral liver cell necrosis associated with the use of high-dose intravenous methylprednisolone. Dig Dis Sci (2007) 0.75